A double-blind vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of melasma in females

Journal of Cosmetic Dermatology

Volumn 13, Issue 2, 2014, Pages 86-90

  Katoulis, Alexander ^a   Alevizou, Antigoni ^a   Soura, Efthymia ^a   Mantas, Nikolaos ^a   Bozi, Evangelia ^a   Gregoriou, Stamatis ^a   Makris, Michalis ^a   Rigopoulos, Dimitris ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Melanogenesis; Melasma; Topical treatment; Undecylenoyl phenylalanine; melanocyte stimulating hormone; adrenergic receptors

Indexed keywords

DEPIGMENTING AGENT; PHENYLALANINE DERIVATIVE; UNCLASSIFIED DRUG; UNDECYLENOYL PHENYLALANINE; DERMATOLOGICAL AGENT; LIPOPEPTIDE; N-UNDECYL-10-ENOYLPHENYLALANINE; PHENYLALANINE;

ADULT; APPLICATION SITE BURNING; APPLICATION SITE ERYTHEMA; APPLICATION SITE PRURITUS; ARTICLE; CHLOASMA; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; CREAM; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG SYNTHESIS; FEMALE; FOLLOW UP; HUMAN; PATIENT ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN DEFECT; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; ERYTHEMA; MELANOSIS; MIDDLE AGED; PAIN; PRURITUS; TREATMENT OUTCOME;

ADULT; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; ERYTHEMA; FEMALE; HUMANS; LIPOPEPTIDES; MELANOSIS; MIDDLE AGED; PAIN; PATIENT SATISFACTION; PHENYLALANINE; PRURITUS; TREATMENT OUTCOME;

EID: 84902014244     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/jocd.12089     Document Type: Article

References (20)

1. Rigopoulos D, Gregoriou S, Katsambas A. Hyperpigmentation and melasma. J Cosmet Dermatol 2007; 6: 195-202.
2. Vachiramon V, Suchonwanit P, Thadanipon K. Melasma in men. J Cosmet Dermatol 2012; 11: 151-7.
3. Sheth VM, Pandya AG. Melasma: a comprehensive update: part I. J Am Acad Dermatol 2011; 65: 689-97.
4. Sobhi RM, Sobhi AM. A single-blinded comparative study between the use of glycolic acid 70% peel and the use of topical nanosome vitamin C iontophoresis in the treatment of melasma. J Cosmet Dermatol 2012; 11: 65-71.
5. Bissett DL, Robinson LR, Raleigh PS et al. Reduction in the appearance of facial hyperpigmentation by topical N-undecyl-10-enoyl-L-phenylalanine and its combination with niacinamide. J Cosmet Dermatol 2009; 8: 260-6.
6. Schaffer JV, Bolognia JV. The melanocortin-1 receptor. Red hair and beyond. Arch Dermatol 2001; 134: 1477-85.
7. Rouzaud F, Hearing VJ. Regulatory elements of the melanocortin 1 receptor. Peptides 2005; 26: 1858-70.
8. Abdel-Malek Z, Swope VB, Suzuki I et al. Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. Proc Natl Acad Sci USA 1995; 92: 1789-93.
9. Pey AL, Martinez A, Charubala R et al. Specific interaction of the diastereomers 7(R)- and 7(S)-tetrahydrobiopterin with phenylalanine hydroxylase: implications for understanding primapterinuria and vitiligo. FASEB J 2006; 20: 2130-2.
10. Im S, Moro O, Peng F et al. Activation of cyclic AMP pathway by alpha-melanotropin mediates the response of human melanocytes to ultraviolet B radiation. Cancer Res 1998; 58: 47-54.
11. Bastiaens M, Ter Huurne J, Gruis N et al. The melanocortin-1-receptor gene is the major freckle gene. Hum Mol Genet 2001; 10: 1701-8.
12. Maeda K, Naganuma M, Fukuda M et al. Effect of pituitary and ovarian hormones on human melanocytes in vitro. Pigment Cell Res 1996; 9: 204-12.
13. Snell RS. Hormonal control of pigmentation in man and other mammals. In: W Montagna, ed. Advances of the Biology of Skin, Vol. 8. The Pigmentary System. Oxford: Pergamon; 1967: pp. 447-66.
14. Slominski A, Tobin DJ, Shibahara S et al. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 2004; 84: 1155-228.
15. Sivamani RK, Lam ST, Isseroff RR. Beta adrenergic receptors in keratinocytes. Dermatol Clin 2007; 25: 643-53.
16. Grando SA, Pittelkow MR, Schallreuter KU. Adrenergic and cholinergic control in the biology of epidermis: physiological and clinical significance. J Invest Dermatol 2006; 126: 1948-65.
17. Katoulis AC, Alevizou A, Bozi E et al. A randomized, double-blind, vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of solar lentigines. Clin Exp Dermatol 2010; 35: 473-6.
18. Dreher F, Draelos ZD, Gold MH et al. Efficacy of hydroquinone-free skin-lightening cream for photoaging. J Cosmet Dermatol 2013; 12: 12-7.
19. Gold MH, Biron J. Efficacy of a novel hydroquinone-free skin-brightening cream in patients with melasma. J Cosmet Dermatol 2011; 10: 189-96.
20. Thirion L, Perard-Francimont C, Pierard GE. Whitening effect of a dermocosmetic formulation: a double-blind controlled study on melasma. Int J Cosmet Sci 2006; 28: 236-7.